QQQ   269.08 (-0.11%)
AAPL   438.68 (+0.67%)
MSFT   212.10 (-2.05%)
FB   248.77 (-1.27%)
GOOGL   1,464.97 (-1.20%)
AMZN   3,111.15 (-0.02%)
NVDA   445.56 (+1.17%)
CGC   18.94 (-0.63%)
BABA   261.47 (+1.37%)
TSLA   1,467.50 (-1.18%)
MU   50.89 (+0.99%)
GE   6.15 (+0.65%)
AMD   85.56 (+10.16%)
T   30.00 (+1.28%)
F   6.78 (+1.19%)
ACB   10.53 (+1.06%)
GILD   70.61 (-1.56%)
NFLX   504.90 (+1.26%)
DIS   117.63 (+1.10%)
BAC   25.01 (+0.08%)
BA   165.62 (+2.06%)
QQQ   269.08 (-0.11%)
AAPL   438.68 (+0.67%)
MSFT   212.10 (-2.05%)
FB   248.77 (-1.27%)
GOOGL   1,464.97 (-1.20%)
AMZN   3,111.15 (-0.02%)
NVDA   445.56 (+1.17%)
CGC   18.94 (-0.63%)
BABA   261.47 (+1.37%)
TSLA   1,467.50 (-1.18%)
MU   50.89 (+0.99%)
GE   6.15 (+0.65%)
AMD   85.56 (+10.16%)
T   30.00 (+1.28%)
F   6.78 (+1.19%)
ACB   10.53 (+1.06%)
GILD   70.61 (-1.56%)
NFLX   504.90 (+1.26%)
DIS   117.63 (+1.10%)
BAC   25.01 (+0.08%)
BA   165.62 (+2.06%)
QQQ   269.08 (-0.11%)
AAPL   438.68 (+0.67%)
MSFT   212.10 (-2.05%)
FB   248.77 (-1.27%)
GOOGL   1,464.97 (-1.20%)
AMZN   3,111.15 (-0.02%)
NVDA   445.56 (+1.17%)
CGC   18.94 (-0.63%)
BABA   261.47 (+1.37%)
TSLA   1,467.50 (-1.18%)
MU   50.89 (+0.99%)
GE   6.15 (+0.65%)
AMD   85.56 (+10.16%)
T   30.00 (+1.28%)
F   6.78 (+1.19%)
ACB   10.53 (+1.06%)
GILD   70.61 (-1.56%)
NFLX   504.90 (+1.26%)
DIS   117.63 (+1.10%)
BAC   25.01 (+0.08%)
BA   165.62 (+2.06%)
QQQ   269.08 (-0.11%)
AAPL   438.68 (+0.67%)
MSFT   212.10 (-2.05%)
FB   248.77 (-1.27%)
GOOGL   1,464.97 (-1.20%)
AMZN   3,111.15 (-0.02%)
NVDA   445.56 (+1.17%)
CGC   18.94 (-0.63%)
BABA   261.47 (+1.37%)
TSLA   1,467.50 (-1.18%)
MU   50.89 (+0.99%)
GE   6.15 (+0.65%)
AMD   85.56 (+10.16%)
T   30.00 (+1.28%)
F   6.78 (+1.19%)
ACB   10.53 (+1.06%)
GILD   70.61 (-1.56%)
NFLX   504.90 (+1.26%)
DIS   117.63 (+1.10%)
BAC   25.01 (+0.08%)
BA   165.62 (+2.06%)
Log in

NYSE:TMOThermo Fisher Scientific Stock Price, Forecast & News

$414.70
-4.39 (-1.05 %)
(As of 08/4/2020 01:14 PM ET)
Add
Compare
Today's Range
$414.44
Now: $414.70
$421.65
50-Day Range
$339.76
MA: $378.49
$413.95
52-Week Range
$250.21
Now: $414.70
$423.70
Volume21,627 shs
Average Volume1.29 million shs
Market Capitalization$163.79 billion
P/E Ratio44.88
Dividend Yield0.21%
Beta1.07
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. It serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
Read More
Thermo Fisher Scientific logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 3.6Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.86 out of 5 stars


Industry, Sector and Symbol

Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryLife Sciences Tools & Services
SectorMedical
CUSIP88355610
Phone781-622-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$25.54 billion
Cash Flow$18.12 per share
Book Value$74.00 per share

Profitability

Net Income$3.70 billion

Miscellaneous

Employees75,000
Market Cap$163.79 billion
Next Earnings Date10/28/2020 (Estimated)
OptionableOptionable
$414.70
-4.39 (-1.05 %)
(As of 08/4/2020 01:14 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TMO News and Ratings via Email

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Thermo Fisher Scientific (NYSE:TMO) Frequently Asked Questions

How has Thermo Fisher Scientific's stock been impacted by COVID-19 (Coronavirus)?

Thermo Fisher Scientific's stock was trading at $289.38 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TMO shares have increased by 43.4% and is now trading at $414.94.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Thermo Fisher Scientific?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last year. There are currently 2 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Thermo Fisher Scientific
.

When is Thermo Fisher Scientific's next earnings date?

Thermo Fisher Scientific is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Thermo Fisher Scientific
.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc. (NYSE:TMO) posted its quarterly earnings data on Wednesday, July, 22nd. The medical research company reported $3.89 EPS for the quarter, beating the consensus estimate of $2.67 by $1.22. The medical research company earned $6.92 billion during the quarter, compared to analysts' expectations of $6.91 billion. Thermo Fisher Scientific had a return on equity of 18.18% and a net margin of 14.12%. During the same quarter in the prior year, the business earned $3.04 EPS.
View Thermo Fisher Scientific's earnings history
.

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific announced a quarterly dividend on Thursday, July 9th. Investors of record on Tuesday, September 15th will be paid a dividend of $0.22 per share on Thursday, October 15th. This represents a $0.88 annualized dividend and a yield of 0.21%. The ex-dividend date is Monday, September 14th.
View Thermo Fisher Scientific's dividend history
.

How will Thermo Fisher Scientific's stock buyback program work?

Thermo Fisher Scientific announced that its board has initiated a share repurchase plan on Friday, November 8th 2019, which permits the company to repurchase $2,500,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board believes its stock is undervalued.

What guidance has Thermo Fisher Scientific issued on next quarter's earnings?

Thermo Fisher Scientific issued an update on its second quarter 2020 Pre-Market earnings guidance on Monday, July, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $6.948-6.948 billion, compared to the consensus revenue estimate of $5.82 billion.

What price target have analysts set for TMO?

14 brokers have issued 1-year price objectives for Thermo Fisher Scientific's stock. Their forecasts range from $330.00 to $475.00. On average, they expect Thermo Fisher Scientific's share price to reach $420.50 in the next twelve months. This suggests a possible upside of 1.3% from the stock's current price.
View analysts' price targets for Thermo Fisher Scientific
.

Has Thermo Fisher Scientific been receiving favorable news coverage?

Media coverage about TMO stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Thermo Fisher Scientific earned a media sentiment score of -1.7 on InfoTrie's scale. They also assigned news stories about the medical research company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near future.
View the latest news about Thermo Fisher Scientific
.

Are investors shorting Thermo Fisher Scientific?

Thermo Fisher Scientific saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 3,660,000 shares, an increase of 6.1% from the June 15th total of 3,450,000 shares. Based on an average trading volume of 1,740,000 shares, the days-to-cover ratio is currently 2.1 days. Approximately 0.9% of the shares of the company are short sold.
View Thermo Fisher Scientific's Current Options Chain
.

Who are some of Thermo Fisher Scientific's key competitors?

What other stocks do shareholders of Thermo Fisher Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Thermo Fisher Scientific investors own include Home Depot (HD), Alibaba Group (BABA), Walt Disney (DIS), Johnson & Johnson (JNJ), Cisco Systems (CSCO), CVS Health (CVS), Honeywell International (HON), NVIDIA (NVDA), Visa (V) and Procter & Gamble (PG).

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the following people:
  • Mr. Marc N. Casper, CEO, Pres & Director (Age 51)
  • Mr. Stephen Williamson, Sr. VP & CFO (Age 52)
  • Mr. Mark P. Stevenson, Exec. VP & COO (Age 56)
  • Mr. Gregory J. Herrema, Sr. VP & Pres of Customer Channels (Age 53)
  • Mr. Patrick M. Durbin, Sr. VP & Pres of Specialty Diagnostics (Age 52)

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

Who are Thermo Fisher Scientific's major shareholders?

Thermo Fisher Scientific's stock is owned by many different retail and institutional investors. Top institutional shareholders include Copper Rock Capital Partners LLC (0.51%), Sumitomo Mitsui Trust Holdings Inc. (0.50%), NN Investment Partners Holdings N.V. (0.25%), Cantillon Capital Management LLC (0.25%), NN Investment Partners Holdings N.V. (0.24%) and New York State Teachers Retirement System (0.16%). Company insiders that own Thermo Fisher Scientific stock include C Martin Harris, Gregory J Herrema, Jim P Manzi, Marc N Casper, Mark Stevenson, Peter E Hornstra, Stephen Williamson, Syed A Jafry and Tyler Jacks.
View institutional ownership trends for Thermo Fisher Scientific
.

Which major investors are selling Thermo Fisher Scientific stock?

TMO stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Assenagon Asset Management S.A., Ziegler Capital Management LLC, First Trust Advisors LP, Huntington National Bank, Montag & Caldwell LLC, Strs Ohio, and Robecosam AG. Company insiders that have sold Thermo Fisher Scientific company stock in the last year include Jim P Manzi, Marc N Casper, Mark Stevenson, Stephen Williamson, and Syed A Jafry.
View insider buying and selling activity for Thermo Fisher Scientific
.

Which major investors are buying Thermo Fisher Scientific stock?

TMO stock was purchased by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, Railway Pension Investments Ltd, PGGM Investments, Candriam Luxembourg S.C.A., Raymond James Financial Services Advisors Inc., Envestnet Asset Management Inc., Pacer Advisors Inc., and Swarthmore Group Inc..
View insider buying and selling activity for Thermo Fisher Scientific
.

How do I buy shares of Thermo Fisher Scientific?

Shares of TMO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of TMO stock can currently be purchased for approximately $414.94.

How big of a company is Thermo Fisher Scientific?

Thermo Fisher Scientific has a market capitalization of $163.88 billion and generates $25.54 billion in revenue each year. The medical research company earns $3.70 billion in net income (profit) each year or $12.35 on an earnings per share basis. Thermo Fisher Scientific employs 75,000 workers across the globe.

What is Thermo Fisher Scientific's official website?

The official website for Thermo Fisher Scientific is www.thermofisher.com.

How can I contact Thermo Fisher Scientific?

Thermo Fisher Scientific's mailing address is 168 Third Avenue, Waltham MA, 02451. The medical research company can be reached via phone at 781-622-1000 or via email at [email protected]

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.